NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
Stanford University
Emory University
Ohio State University
Endeavor Biomedicines, Inc.
Replimune Inc.